RELATED STUDY
Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews
Key Findings: This scoping review of systematic reviews finds that adverse events associated with the use of medicinal cannabis, such as decreased alertness and reaction times, increased workplace risks, increased absenteeism, and reduced ability to safely drive or operate machinery and increased the probability of falling.
Type of Study: Meta-analysis
Study Sample Size: 31
Study Result: Negative
Research Location(s): Australia
Year of Pub: 2023
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified), Synthetic Cannabinoid (unspecified), Pharma THC, Pharma THC:CBD
Phytocannabinoid Source: Not Applicable
DOSING DETAILS 
Study Dosing Objective: Safety Profile,
Established Protocol: Adverse effects
Route of Administration: , Inhalation, Injection, Oral (Ingestion), Sublingual/Oromucosal
Clinical Relevance: Cannabis use is associated with increased workplace health and safety risks. These include reduced alertness and reaction times, increased absenteeism, decreased ability to operate machinery safely, and an increased probability of falling.
Adverse Events: AEs: dizziness, dry mouth, nausea, vomiting, fatigue SAEs: urinary tract infection, pneumonia, fracture from fall due to dizziness, suicidal ideation, trans-ischemic attack, death, seizure, suicidal behaviors, serious disorientation, intolerable confusion, and severe euphoria
Citation: (None). Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews. Workplace Health Saf. 2023; 71:411. doi: 10.1177/21650799231172722
Authors: N/A
